Morepen Laboratories Limited (NSE:MOREPENLAB)
India · Delayed Price · Currency is INR 47.20
+0.56 (1.20%)
Aug 13, 2025, 3:30 PM IST
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 25.58 billion as of August 13, 2025. Its market cap has decreased by -14.05% in one year.
Market Cap
25.58B
Enterprise Value
25.67B
Revenue
18.01B
Ranking
n/a
PE Ratio
27.63
Stock Price
47.20
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 25.58B, an increase of 195.50%. That is a compound annual growth rate of 4.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 25.58B | -40.37% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | 13.81B | 97.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.50B |
| Divi's Laboratories | 1,590.69B |
| Cipla | 1,200.16B |
| Apollo Hospitals Enterprise | 1,043.73B |
| Mankind Pharma | 1,006.03B |
| Zydus Lifesciences | 941.99B |
| Fortis Healthcare | 695.05B |
| Aurobindo Pharma | 605.25B |